Company Overview

Founded in 2008, Biocytogen is a premier research partner that provides the proprietary gene editing services. We developed CRISPR/Cas9 based innovative Extreme Genome Editing (EGE) system, which has about 20 fold higher efficiency for large fragment knockin on mice, rats and cell lines. By outsourcing your gene editing projects to our team of experts at Biocytogen, you can rest assured that you’ll have your projects done at the fastest timeline, no financial and time risk and best technical support before and after project delivery. Over the past decade, Biocytogen has grown into a global leader in the field of gene editing and animal model generation services. We offer seamless collaboration, cutting-edge technology platforms, customization capabilities, outstanding service, quick timelines, a vast collection of gene humanized mouse models for research and drug screening/evaluation. We generate about 1500 mouse/rat models each year for worldwide customers with 98% plus success rate.

Contact (1)
None yet.